Milestone Pharmaceuticals Inc.
MIST Nasdaq
SEC CIK 1408443
Follow Milestone Pharmaceuticals
Weekly email: filings, results
Revenue, last quarter
$963K
Net income
−$25.8M
−116.4% vs same quarter last year
EPS, diluted
−$0.18
−50% vs same quarter last year
Operating cash flow
−$25.2M
−158.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$63.1K |
| FY24 | −$41.5K |
| FY23 | −$59.7K |
| FY22 | −$58.4M |
| FY21 | −$42.9M |
| FY20 | −$50M |
| FY19 | −$55.2M |
| FY18 | - |
| FY17 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$49.3M |
| FY24 | −$28.9M |
| FY23 | −$46.5M |
| FY22 | −$52.7M |
| FY21 | - |
| FY20 | - |
| FY19 | −$51.6M |
| FY18 | −$21.1M |
| FY17 | - |